Suggested is a composition comprising (a) sclareolide and (b1) at least one tyrosinase inhibitor； and/or (b2) at least one sun protection factor； and/or (b3) at least one anti-oxidants； and/or (b4) at least one anti-inflammatory agent； and/or (b5) at least one desquamating agent, on condition that compound a is present in an amount of from 0.00001 to 0.001% b.w.—calculated on the total composition.
